Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.17 (
CaMKII
)
4,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nerve-induced muscle activity suppresses nicotinic acetylcholine receptor (nAChR) gene expression by increasing intracellular calcium levels. This suppression is mediated by nAChR promoter sequences harboring at least 1 E-box (CANNTG) that bind myogenic helix-loop-helix transcription factors. How muscle depolarization or increased calcium mediates changes in nAChR promoter activity is not well understood. In chick muscle, protein kinase C (PKC) activation is necessary for activity-dependent nAChR gene suppression. Similar effects of PKC activation have not been found in mammalian skeletal muscle. Therefore, we used rat primary muscle cultures to screen for other calcium-regulated enzymatic activities that may mediate the effects of muscle activity and calcium on nAChR promoter activity. We report here that calcium/calmodulin-dependent protein kinase II (
CaM kinase II
) can specifically suppress nAChR promoter activity in mammalian muscle. This regulation was mediated by a single E-box sequence residing in the previously characterized nAChR delta-subunit genes 47-base pair activity-dependent enhancer. In vitro protein/DNA interaction studies suggest that
CaM kinase II
inhibits binding of the myogenic factor,
myogenin
, to the delta-promoter 47-base pair activity-dependent enhancer.
CaM kinase
activity is increased in active muscle and inhibition of this enzymatic activity results in increased nAChR delta-promoter activity. Therefore,
CaM kinase II
may represent a previously unappreciated activity that participates in coupling muscle depolarization to nAChR gene expression.
...
PMID:CaM kinase II-dependent suppression of nicotinic acetylcholine receptor delta-subunit promoter activity. 1135 Sep 61
Gene expression in skeletal muscle is regulated by a family of myogenic basic helix-loop-helix (bHLH) proteins. The binding of these bHLH proteins, notably MyoD and
myogenin
, to E-boxes in their own regulatory regions is blocked by protein kinase C (PKC)-mediated phosphorylation of a single threonine residue in their basic region. Because electrical stimulation increases PKC activity in skeletal muscle, these data have led to an attractive model suggesting that electrical activity suppresses gene expression by stimulating phosphorylation of this critical threonine residue in myogenic bHLH proteins. We show that electrical activity stimulates phosphorylation of
myogenin
at threonine 87 (T87) in vivo and that
calmodulin-dependent kinase II
(
CaMKII
), as well as PKC, catalyzes this reaction in vitro. We find that phosphorylation of
myogenin
at T87 is dispensable for skeletal muscle development. We show, however, that the decrease in
myogenin
(myg) expression following innervation is delayed and that the increase in expression following denervation is accelerated in mutant mice lacking phosphorylation of
myogenin
at T87. These data indicate that two distinct innervation-dependent mechanisms restrain
myogenin
activity: an inactivation mechanism mediated by phosphorylation of
myogenin
at T87, and a second, novel regulatory mechanism that regulates myg gene activity independently of T87 phosphorylation.
...
PMID:Accelerated response of the myogenin gene to denervation in mutant mice lacking phosphorylation of myogenin at threonine 87. 1496 78